DeutschNewstral
Article
Iinvezz.com on 2024-05-10 11:53
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses
Related news
- MNovavax inventory jumps on Sanofi Covid vaccine dealmvtelegraph.com
- MC4X Discovery shares jump on Sanofi licensing dealmarketwatch.com
Sanofi SA: Sanofi-Novavax licensing deal looks to boost post-pandemic vaccine salesFinancial Times
Sanofi Genzyme sees 20 percent growth in sales in Q1bizjournals.com- Novavax shares jump on news of narrowed first-quarter lossesbizjournals.com
Novavax Shares Surge Over 140% After $1.4 Billion Covid Shot Deal With SanofiForbes
Sanofi Names Brandicourt CEOwsj.com- Consumer Stockpiling Boosts Sanofi Saleswsj.com
- Sanofi Profit Hit By Falling Diabetes Revenuewsj.com
- MSanofi lifts business guidance as profit growsmarketwatch.com
- MSanofi to buy UK biopharmaceutical group Kymabmarketwatch.com
- MSanofi to invest in Singapore vaccine productionmarketwatch.com
- Sanofi Buoyed by Biotech and Lower Costswsj.com
- Sanofi Wins Approval For New Insulin Drugwsj.com
- How a Sanofi Diabetes Bet Went Wrongwsj.com
- MSanofi to help manufacture Pfizer/BioNTech vaccinemarketwatch.com
- Sanofi Stops Work on Two Zika Vaccineswsj.com
- Sanofi Profit Up as Charges Fallwsj.com
- MSanofi to acquire Synthorx for $2.5 billionmarketwatch.com
- Sanofi Ends a Covid-19 Vaccine Effortwsj.com